TECX - NASDAQ

Tectonic Therapeutic, Inc.

TECX·NASDAQ

$29.13

+6.2%

HealthcareBiotechnology

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$549.66M

EPS-4.0500

P/E Ratio-7.19

Earnings Date08/06/2026

tecx

Net Cash Provided by Investing Activities

Last Annual Value

-138.00K

3-Year CAGR

20%

5-Year CAGR

35%

10-Year CAGR

-19%

Adjust for Inflation

Tectonic Therapeutic, Inc. Competitors Analysis of Net Cash Provided by Investing Activities

TECX · NASDAQ

Company	Net Cash Provided by Investing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Tectonic Therapeutic, Inc. NASDAQ:TECX	-138.00K	N/A	N/A	N/A
Neumora Therapeutics, Inc. Common Stock NASDAQ:NMRA	168.52M	37.8%	N/A	N/A
Alector, Inc. NASDAQ:ALEC	196.60M	24.5%	N/A	N/A
Capricor Therapeutics, Inc. NASDAQ:CAPR	97.48B	2572.3%	N/A	N/A
Kyverna Therapeutics, Inc. NASDAQ:KYTX	40.02M	N/A	N/A	N/A
Tenaya Therapeutics, Inc. NASDAQ:TNYA	56.08M	4.8%	N/A	N/A
Vanda Pharmaceuticals Inc. NASDAQ:VNDA	94.86M	N/A	N/A	N/A
Aldeyra Therapeutics, Inc. NASDAQ:ALDX	47736.29B	11574.6%	N/A	N/A
Larimar Therapeutics, Inc. NASDAQ:LRMR	100.31M	44.3%	32.9%	6.9%
Lyell Immunopharma, Inc. NASDAQ:LYEL	54.10M	-33.5%	N/A	N/A
Alto Neuroscience, Inc. NYSE:ANRO	-24.00K	N/A	N/A	N/A

Tectonic Therapeutic, Inc. Fair Value Envelope

TECX · NASDAQ

Our analysis suggests that TECX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $29.13, this represents a potential HIDDEN relative to our calculated worth for Tectonic Therapeutic, Inc..

HIDDEN

Intrinsic Value

Current Price: $29.13

Related Guides

Blog Categories

Continue your TECX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.